- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT00895154
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
23 aprile 2019 aggiornato da: Allison King, Washington University School of Medicine
The overall goal of this project is to determine the feasibility of conducting a cognitive intervention for children with sickle cell disease.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The primary aims of this clinical trial are:
- Determine the effectiveness of targeted learning and memory strategy remediation in students with sickle cell disease and cognitive deficits.
- Determine if there is improvement in academic achievement after targeted memory strategy remediation.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
21
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
Missouri
-
Saint Louis, Missouri, Stati Uniti, 63110
- Washington University School of Medicine/St. Louis Children's Hospital
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 8 anni a 18 anni (Bambino, Adulto)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- Sickle cell disease that is confirmed by hemoglobin analysis
- Has a brain magnetic resonance imaging (MRI) document reading by a neuroradiologist
- Cognitive deficits, which are defined by one standard deviation lower than the normal ranges of an age-based standard score in cognitive tests that are evaluated by a psychologist
- Must be a student who will remain in school for at least 2 years
- Must provide informed consent with assent in accordance with the institutional policies (institutional review board approval)
Exclusion Criteria:
- Known developmental delays (these participants are ineligible because their learning potential may be biased from a prior insult)
- Intelligent quotient is less than 50 (may have impaired learning potential)
- Aphasic (i.e., unable to produce intelligible speech)
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Comparatore attivo: General Tutoring Group
Participants will receive general tutoring in the subject of his/her choice.
|
Participants will be tutored for approximately 8-10 hours per month during the school year.
|
Sperimentale: Tutoring + Memory Training Group
Participants will receive tutoring and memory training.
|
Participants will be tutored for approximately 8-10 hours per month during the school year.
Participants will receive memory training for approximately 8-10 hours per month during the school year.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
Full Scale IQ (FSIQ) (WASI)
Lasso di tempo: After >/= 50 hours of tutoring
|
The WASI is a brief, reliable measure of intelligence.
Participants engage in 4 subtests: Block Design, Vocabulary, Similarities, and Matrix Reasoning.
Participants receive a raw score on each of these 4 subtests.
This raw score is converted to a T score using a score chart in the WASI manual.
The T scores from all 4 subtests are summed together to obtain a Full Scale Sum of T Scores.
This Full Scale Sum of T Scores is converted to a Full Scale IQ-4 Composite Score using a score chart published in the WASI manual.
Higher scores indicate better intelligence.
FSIQ-4 Range: 40-160.
Average FSIQ-4 =100, standard deviation is +/- 15.
|
After >/= 50 hours of tutoring
|
Verbal IQ (PIQ) (WASI)
Lasso di tempo: After >/= 50 hours of tutoring
|
The VIQ score is comprised from the Vocabulary and Similarities subtests of the WASI-4.
The raw scores from these subtests are converted to T scores using score charts in the manual.
The T scores are summed together for a Verbal Sum of T Scores.
This score is converted to a Composite VIQ score using a score chart in the manual.
Higher scores = better Verbal IQ.
Range = 45-160.
Average = 100; standard deviation +/- 15.
|
After >/= 50 hours of tutoring
|
Performance IQ (PIQ) (WASI)
Lasso di tempo: After >/= 50 hours of tutoring
|
The PIQ score is comprised from the Matrix Reasoning and Block Design subtests of the WASI-4.
The raw scores from these subtests are converted to T scores using score charts in the manual.
The T scores are summed together for a Performance Sum of T Scores.
This score is converted to a Composite PIQ score using a score chart in the manual.
Higher scores = better Performance IQ.
Range = 45-160.
Average = 100; standard deviation +/- 15.
|
After >/= 50 hours of tutoring
|
Letter Word Identification T Score (WJ-III)
Lasso di tempo: After >/= 50 hours of tutoring
|
This sub-test measures a student's word identification skills.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
Reading Fluency T Score (WJ-III)
Lasso di tempo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to read simple sentences quickly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
Calculations T Score (WJ-III)
Lasso di tempo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to perform paper and pencil math computations.A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
Math Fluency T Score (WJ-III)
Lasso di tempo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to solve simple addition, subtraction and multiplication facts quickly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
Spelling T Score (WJ-III)
Lasso di tempo: After >/= 50 hours of tutoring
|
This sub-test measures a student's ability to write orally presented words correctly.
A participant's raw score (# of items answered correctly) is converted to a T score using a program (Compuscore for the WJ III, Version 2.1).
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
California Verbal Learning Test-Children's Version (CVLT-C) List A Trials 1-5 Immediate Recall T Score
Lasso di tempo: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
CVLT-C Trials 1-5 Semantic Clustering T Score
Lasso di tempo: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The CVLT-C consists of five learning trials of 15 words which can be organized into three semantic categories.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
CVLT-C Trials 1-5 Short Delay Recall T Score
Lasso di tempo: After >/= 50 hours of tutoring
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
CVLT-C Trials 1-5 Long Delay Recall T Score
Lasso di tempo: T scores were obtained at baseline and again at follow-up (after partcipant completed 50 hours of tutoring)
|
The CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
T scores were obtained at baseline and again at follow-up (after partcipant completed 50 hours of tutoring)
|
CVLT-C Trials 1-5 Recognition Discriminability T Score
Lasso di tempo: After >/= 50 hours of tutoring
|
TThe CVLT®-C measures multi-trial learning and long-term recall abilities for verbal information.
The Raw scores from all trials (1-5) are summed to calculate a Total Raw Score for Trials 1-5.
This Raw score is converted to a T score using the CVLT-II Comprehensive Scoring System (computer system).
A higher T score indicates better performance.
Range = 0-100.
Average =50 with a standard deviation of =/- 10 points.
|
After >/= 50 hours of tutoring
|
Delis Kaplan Executive Function System (D-KEFS) Number/Letter Switching T Score
Lasso di tempo: After >/= 50 hours of tutoring
|
The D-KEFS allows for the assessment of executive functions.
There are 9 stand alone tests that can be individually or group administered.
The Number-Letter Switching condition of the Trails Making sub-test specifically assesses flexibility of thinking on a visual-motor sequencing task.
A participant's raw score (# of items answered correctly) is converted to a T score using tables provided in the manual.
Higher T scores = better performance.
Range: 0-100.
Average T score = 50; standard deviation =/- 10.
|
After >/= 50 hours of tutoring
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Collaboratori
Investigatori
- Investigatore principale: Allison King, MD, MPH, Washington University School of Medicine
Pubblicazioni e link utili
La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.
Pubblicazioni generali
- Yerys BE, White DA, Salorio CF, McKinstry R, Moinuddin A, DeBaun M. Memory strategy training in children with cerebral infarcts related to sickle cell disease. J Pediatr Hematol Oncol. 2003 Jun;25(6):495-8. doi: 10.1097/00043426-200306000-00014.
- King AA, White DA, McKinstry RC, Noetzel M, Debaun MR. A pilot randomized education rehabilitation trial is feasible in sickle cell and strokes. Neurology. 2007 Jun 5;68(23):2008-11. doi: 10.1212/01.wnl.0000264421.24415.16.
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio
1 settembre 2003
Completamento primario (Effettivo)
1 luglio 2014
Completamento dello studio (Effettivo)
1 dicembre 2014
Date di iscrizione allo studio
Primo inviato
6 maggio 2009
Primo inviato che soddisfa i criteri di controllo qualità
6 maggio 2009
Primo Inserito (Stima)
8 maggio 2009
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
15 maggio 2019
Ultimo aggiornamento inviato che soddisfa i criteri QC
23 aprile 2019
Ultimo verificato
1 aprile 2019
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 653
- K23HL079073 (Sovvenzione/contratto NIH degli Stati Uniti)
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Anemia falciforme
-
Genentech, Inc.ReclutamentoMelanoma | Cancro cervicale | HCC | Tumore gastrico | Cancro esofageo | NSCLC | Carcinoma uroteliale | HNSCC | Tumori solidi localmente avanzati o metastatici | TNBC | Clear Cell RCCCorea, Repubblica di, Olanda, Spagna, Stati Uniti, Australia, Canada, Belgio
-
The Netherlands Cancer InstitutePfizerReclutamentoCarcinoma a cellule renaliOlanda
-
National Cancer Centre, SingaporeTerminatoLINFOMA EXTRANODALE NK-T-CELLSingapore
-
Medical College of WisconsinUniversity of Wisconsin, Madison; AmgenReclutamentoLeucemia linfoblastica acuta a cellule B | Leucemia linfoblastica acuta infantile a cellule B | B-Cell ALL, InfanziaStati Uniti
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Southwest Oncology Group; Cancer and Leukemia Group BCompletatoCarcinoma a cellule renali a cellule chiare | Cancro a cellule renali in stadio III AJCC v7 | Cancro a cellule renali in stadio II AJCC v7 | Stadio I Renal Cell Cancer AJCC v6 e v7Stati Uniti, Canada, Porto Rico
-
National Cancer Institute (NCI)TerminatoCarcinoma a cellule renali a cellule chiare | Carcinoma a cellule renali metastatico | Cancro a cellule renali in stadio III AJCC v7 | Cancro a cellule renali in stadio IV AJCC v7 | Cancro a cellule renali in stadio II AJCC v7 | Stadio I Renal Cell Cancer AJCC v6 e v7Stati Uniti
-
Peloton Therapeutics, Inc., a subsidiary of Merck...National Institutes of Health (NIH)CompletatoCarcinoma a cellule renali a cellule chiare | Malattia di Von Hippel-Lindau | Clear Cell RCC | ccRCC | Mutazione del gene VHL | Sindrome VHL | Inattivazione del gene VHL | VHL | Von Hippel | Malattia di Von Hippel | Sindrome di von Hippel-Lindau, modificatori diStati Uniti
Prove cliniche su General Tutoring
-
Montefiore Medical CenterRitiratoArresto cardiaco | Scompenso cardiaco acuto scompensato
-
Hospital Civil de GuadalajaraReclutamentoSindrome da distress respiratorio acutoMessico
-
Consorci d'Atenció Primària de Salut de l'EixampleCompletatoIpertensione | Aneurisma dell'aorta addominale | AteromatosiSpagna
-
Consorci d'Atenció Primària de Salut de l'EixampleMedtronicCompletatoAneurisma dell'aorta addominaleSpagna
-
Hamilton Health Sciences CorporationCompletatoDisfunsione dell'arteria coronariaCanada
-
King Fahad Medical CitySconosciutoCambiamenti di temperatura corporea | Durata del soggiorno | Pre-termine | Transizione | Dimissione del paziente
-
Region SkaneCompletato
-
University Hospital, Clermont-FerrandSconosciuto
-
Brigham and Women's HospitalDepartment of Health and Human Services; Centers for Medicare and Medicaid Services e altri collaboratoriCompletatoInfluenza | Influenza, umana | Influenza umanaStati Uniti
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... e altri collaboratoriCompletato